Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HIF inhibitors(Hypoxia inducible factors inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H11Cl2N3O5 |
InChIKeyIVVBSKSURSLYFK-UHFFFAOYSA-N |
CAS Registry2962103-54-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fatty Liver | Preclinical | GB | 21 Oct 2024 | |
Fatty Liver | Preclinical | CN | 21 Oct 2024 | |
Obesity | Preclinical | GB | 21 Oct 2024 | |
Obesity | Preclinical | CN | 21 Oct 2024 |